What's in Shanghai Ark Biopharmaceutical Co., Ltd.'s pipeline?

Shanghai Ark Biopharmaceutical Co., Ltd. has 6 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Shanghai Ark Biopharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Bayer, Beta Pharma Shanghai, Betta Pharmaceuticals Co., Ltd., Caliway Biopharmaceuticals Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shanghai-ark-biopharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Shanghai Ark Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shanghai Ark Biopharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
AK0901 capsule	AK0901 capsule	phase 3
Matching placebo of AK0529	Matching placebo of AK0529	phase 3
AK0529	AK0529	phase 3	FGFR inhibitor	FGFR (Fibroblast Growth Factor Receptor)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Beta Pharma Shanghai · 1 shared drug class
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Caliway Biopharmaceuticals Co., Ltd. · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
Eisai Inc. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Allist Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shanghai Ark Biopharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Shanghai Ark Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shanghai-ark-biopharmaceutical-co-ltd. Accessed 2026-05-17.